283 related articles for article (PubMed ID: 28237877)
1. Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells.
Tang ZH; Cao WX; Su MX; Chen X; Lu JJ
Toxicol Appl Pharmacol; 2017 Apr; 321():18-26. PubMed ID: 28237877
[TBL] [Abstract][Full Text] [Related]
2. Induction of reactive oxygen species-stimulated distinctive autophagy by chelerythrine in non-small cell lung cancer cells.
Tang ZH; Cao WX; Wang ZY; Lu JH; Liu B; Chen X; Lu JJ
Redox Biol; 2017 Aug; 12():367-376. PubMed ID: 28288416
[TBL] [Abstract][Full Text] [Related]
3. Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line.
Tang ZH; Jiang XM; Guo X; Fong CM; Chen X; Lu JJ
Oncotarget; 2016 Dec; 7(49):81598-81610. PubMed ID: 27835594
[TBL] [Abstract][Full Text] [Related]
4. EGFR tyrosine kinase inhibitor Almonertinib induces apoptosis and autophagy mediated by reactive oxygen species in non-small cell lung cancer cells.
Ge X; Zhang Y; Huang F; Wu Y; Pang J; Li X; Fan F; Liu H; Li S
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S49-S62. PubMed ID: 34219533
[TBL] [Abstract][Full Text] [Related]
5. Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells.
Jiang XM; Xu YL; Huang MY; Zhang LL; Su MX; Chen X; Lu JJ
Acta Pharmacol Sin; 2017 Nov; 38(11):1512-1520. PubMed ID: 28880013
[TBL] [Abstract][Full Text] [Related]
6. AZD9291 promotes autophagy and inhibits PI3K/Akt pathway in NSCLC cancer cells.
Zhang Z; Zhang M; Liu H; Yin W
J Cell Biochem; 2019 Jan; 120(1):756-767. PubMed ID: 30145802
[TBL] [Abstract][Full Text] [Related]
7. 7-O-geranylquercetin-induced autophagy contributes to apoptosis via ROS generation in human non-small cell lung cancer cells.
Wang EX; Zou BY; Shi L; Du LY; Zhu YY; Jiang YM; Ma XD; Kang XH; Wang CY; Zhen YH; Sun LD
Life Sci; 2017 Jul; 180():102-113. PubMed ID: 28495516
[TBL] [Abstract][Full Text] [Related]
8. Phanginin R Induces Cytoprotective Autophagy via JNK/c-Jun Signaling Pathway in Non-Small Cell Lung Cancer A549 Cells.
Zhang LL; Bao H; Xu YL; Jiang XM; Li W; Zou L; Lin LG; Lu JJ
Anticancer Agents Med Chem; 2020; 20(8):982-988. PubMed ID: 32286950
[TBL] [Abstract][Full Text] [Related]
9. Osimertinib resistance in non-small cell lung cancer: Mechanisms and therapeutic strategies.
Tang ZH; Lu JJ
Cancer Lett; 2018 Apr; 420():242-246. PubMed ID: 29425688
[TBL] [Abstract][Full Text] [Related]
10. Induction of C/EBP homologous protein-mediated apoptosis and autophagy by licochalcone A in non-small cell lung cancer cells.
Tang ZH; Chen X; Wang ZY; Chai K; Wang YF; Xu XH; Wang XW; Lu JH; Wang YT; Chen XP; Lu JJ
Sci Rep; 2016 May; 6():26241. PubMed ID: 27184816
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of IRE1α Associates with the Resistant Mechanism of Osimertinib (AZD9291)-resistant non-small Cell Lung Cancer HCC827/OSIR Cells.
Tang ZH; Su MX; Guo X; Jiang XM; Jia L; Chen X; Lu JJ
Anticancer Agents Med Chem; 2018; 18(4):550-555. PubMed ID: 28730963
[TBL] [Abstract][Full Text] [Related]
12. Identification of compound CA-5f as a novel late-stage autophagy inhibitor with potent anti-tumor effect against non-small cell lung cancer.
Zhang L; Qiang P; Yu J; Miao Y; Chen Z; Qu J; Zhao Q; Chen Z; Liu Y; Yao X; Liu B; Cui L; Jing H; Sun G
Autophagy; 2019 Mar; 15(3):391-406. PubMed ID: 30145925
[TBL] [Abstract][Full Text] [Related]
13. A natural anthraquinone derivative shikonin synergizes with AZD9291 against wtEGFR NSCLC cells through reactive oxygen species-mediated endoplasmic reticulum stress.
Hu X; Zhang ZY; Wu LW; Zeng LH; Chen H; Zhu HJ; Zhang JK; Shao J; Zhang C; Li YL; Lin NM
Phytomedicine; 2020 Mar; 68():153189. PubMed ID: 32070867
[TBL] [Abstract][Full Text] [Related]
14. Thermal treatment decreases resistance to osimertinib in non-small cell lung cancer through the EGFR/PI3K/AKT pathway.
Wang J; Ling X; Zhou M; Ding G; Peng B; Wan J
Neoplasma; 2021 May; 68(3):535-545. PubMed ID: 33724860
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol analogue 3,4,4'-trihydroxy-trans-stilbene induces apoptosis and autophagy in human non-small-cell lung cancer cells in vitro.
Zhang L; Dai F; Sheng PL; Chen ZQ; Xu QP; Guo YQ
Acta Pharmacol Sin; 2015 Oct; 36(10):1256-65. PubMed ID: 26190500
[TBL] [Abstract][Full Text] [Related]
16. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
17. Pseudolaric acid B suppresses NSCLC progression through the ROS/AMPK/mTOR/autophagy signalling pathway.
Luo D; He F; Liu J; Dong X; Fang M; Liang Y; Chen M; Gui X; Wang W; Zeng L; Fan X; Wu Q
Biomed Pharmacother; 2024 Jun; 175():116614. PubMed ID: 38670047
[TBL] [Abstract][Full Text] [Related]
18. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production.
Kim Y; Kim YS; Kim DE; Lee JS; Song JH; Kim HG; Cho DH; Jeong SY; Jin DH; Jang SJ; Seol HS; Suh YA; Lee SJ; Kim CS; Koh JY; Hwang JJ
Autophagy; 2013 Dec; 9(12):2126-39. PubMed ID: 24322755
[TBL] [Abstract][Full Text] [Related]
19. Exopolysaccharide from Cryptococcus heimaeyensis S20 induces autophagic cell death in non-small cell lung cancer cells via ROS/p38 and ROS/ERK signalling.
Hao Y; Huang Y; Chen J; Li J; Yuan Y; Wang M; Han L; Xin X; Wang H; Lin D; Peng F; Yu F; Zheng C; Shen C
Cell Prolif; 2020 Aug; 53(8):e12869. PubMed ID: 32597573
[TBL] [Abstract][Full Text] [Related]
20. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.
Li YY; Lam SK; Mak JC; Zheng CY; Ho JC
Lung Cancer; 2013 Sep; 81(3):354-361. PubMed ID: 23769318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
